GeminIQ Website Logo

Viewing ACOG free

Subscribe for full history, 90+ metrics, screener, watchlist...

Alpha Cognition Inc.

ACOG

Companies in Biological Products, (No Diagnostic Substances)

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Related Party
-----110
Assets
Cash And Cash Equivalents At Carrying Value
54663539464941
Restricted Cash Current
00000000
Assets Current
Accounts Receivable Net Current
44320---
Assets Current
69794645485052
Inventory Net
654111--
Prepaid Expense And Other Assets Current
54321110
Other Receivables Net Current
-0---0--
Other Assets Noncurrent
----0000
Property Plant And Equipment Net
00000000
Finite Lived Intangible Assets Net
00000000
Assets
69804645495152
Accounts Payable And Accrued Liabilities Current
59733221
Liabilities Current
Liabilities Current
59733332
Contract With Customer Liability Current
00000-00
Convertible Debt Noncurrent
------1-
Deferred Income Tax Liabilities Net
----0---
Deferred Income Noncurrent
-000----
Derivative Liabilities Noncurrent
-5---6--
Contract With Customer Liability Noncurrent
0-------
Warrants And Rights Outstanding
4-5105621
Other Liabilities Noncurrent
00000000
Liabilities
1217121381283
Common Stock Value
1341341029999994949
Preferred Stock Value
00000000
Stockholders Equity
Additional Paid In Capital
2726222220171918
Stockholders Equity
576334323939-3-1
Accumulated Other Comprehensive Income Loss Net Of…
-0-0-0-0-0-0-0-0
Retained Earnings Accumulated Deficit
-104-97-90-89-78-76-71-69
Liabilities And Stockholders Equity
69804645495152
Preferred Class B
00000000
Common Stock Shares Issued
152152146144144144145151
Shares Outstanding
2222161616161213

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
20262.46%38.91%----------
202537.67%53.67%32.89%11.25%-6.50%-22.62%6.53%6.04%-21.04%24.86%6.56%25.87%
2024-------0.26%-0.09%0.79%-0.40%80.63%81.03%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
12.64
8.65
6.69
14.69
17.14
15.00
1.50
0.96
Quick Ratio
10.67
7.70
5.61
13.58
16.40
14.49
1.26
0.76
Working Capital
63.13M
69.88M
38.87M
41.61M
45.31M
46.90M
1.51M
-57.16K
Leverage & Debt
Debt to Equity
0.21
0.28
0.37
0.41
0.20
0.30
-3.09
-3.33
Interest Coverage TTM
-14.40
-11.87
-47.02
-188.26
-135.15
-
-
-
Debt Ratio
0.17
0.22
0.27
0.29
0.16
0.23
1.58
1.67
Efficiency & Turnover
Asset Turnover TTM
0.18
0.16
0.29
0.19
0.06
-
-
-
Days Sales Outstanding TTM
67.45
151.29
139.85
144.34
52.69
-
-
-
Receivables Turnover TTM
5.41
2.41
2.61
2.53
6.93
-
-
-
Per Share Metrics
Diluted EPS TTM
-1.16
-1.17
-1.51
-1.55
-1.03
-
-
-
Free Cash Flow Per Share TTM
-1.40
-1.17
-0.99
-0.76
-0.62
-
-
-
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
-
-
-
Margin Metrics
Gross Profit Margin TTM
93.57%
95.36%
-
-
-
-
-
-
Operating Profit Margin TTM
-252.66%
-221.72%
-290.25%
-408.46%
-526.44%
-
-
-
Net Profit Margin TTM
-234.84%
-202.24%
-327.79%
-542.64%
-563.87%
-
-
-
Growth Metrics
Net Revenue Growth (1Y)
269.64%
-
-
-
-
-
-
-
Net Income Growth (1Y)
53.95%
-
-
-
-
-
-
-
EPS Growth (1Y)
13.33%
-
-
-
-
-
-
-
Valuation Metrics
P/E TTM
-4.70
-5.56
-4.32
-6.01
-4.91
-
-
-
P/B TTM
2.08
1.84
3.10
4.69
2.11
2.18
-
-
P/S TTM
11.04
11.24
14.15
32.59
27.68
-
-
-
Market Cap
119.47M
114.92M
105.10M
149.47M
81.06M
85.38M
-
-
Enterprise Value
65.17M
48.82M
69.64M
110.01M
35.44M
36.82M
-
-
Calculated Values
Free Cash Flow TTM
-30.37M
-20.67M
-15.92M
-12.14M
-9.86M
-
-
-
Net Debt
-54.31M
-66.11M
-35.46M
-39.46M
-45.62M
-48.56M
-2.77M
-1.19M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-06-26Purchase
Owner: Opaleye, Management Inc.
Title: -
Shares: 152,336
Price/Share: $6.40
Value: $974,950.40
Shares Owned: 2,805,107
Relationship: TenPercentOwner
Ownership: Indirect
2026-06-15Purchase
Owner: Opaleye, Management Inc.
Title: -
Shares: 4,550
Price/Share: $5.99
Value: $27,254.50
Shares Owned: 2,652,574
Relationship: TenPercentOwner
Ownership: Indirect
2026-06-10Purchase
Owner: Opaleye, Management Inc.
Title: -
Shares: 5,872
Price/Share: $5.99
Value: $35,173.28
Shares Owned: 2,644,889
Relationship: TenPercentOwner
Ownership: Indirect
2026-06-05Purchase
Owner: Opaleye, Management Inc.
Title: -
Shares: 10,054
Price/Share: $5.83
Value: $58,614.82
Shares Owned: 2,614,161
Relationship: TenPercentOwner
Ownership: Indirect
2026-05-28Purchase
Owner: Opaleye, Management Inc.
Title: -
Shares: 2,000
Price/Share: $5.83
Value: $11,660.00
Shares Owned: 2,533,530
Relationship: TenPercentOwner
Ownership: Indirect

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
48.12%
Inst. Shares: 10,470,895
Shares Outstanding: 21,762,060
2025-12-31
55.70%
Inst. Shares: 9,847,504
Shares Outstanding: 17,680,597
2025-09-30
69.15%
Inst. Shares: 11,163,050
Shares Outstanding: 16,144,120
2025-06-30
70.52%
Inst. Shares: 11,298,078
Shares Outstanding: 16,020,702
2025-03-31
78.26%
Inst. Shares: 12,536,926
Shares Outstanding: 16,019,787

Alpha Cognition Inc. (ACOG) — SEC Financial Statements & Analysis

Alpha Cognition Inc. (ACOG) is a biological products, (no diagnostic substances) company, incorporated in A1. Alpha Cognition Inc. trades on Nasdaq as: ACOG. Based on its latest SEC filing (Form 10-Q, period ending 2026-03-31), Alpha Cognition Inc. reported a 269.64% year-over-year revenue growth, a Gross Profit Margin of 93.57% (TTM), a Debt-to-Equity ratio of 0.21x, a Price-to-Sales (P/S) ratio of 11.04x (TTM), a Price-to-Book (P/B) ratio of 2.08 (TTM), at a market cap of $119.47M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
269.64%
Gross Profit Margin TTM
93.57%
Debt To Equity
0.21x
P/S TTM
11.04x
P/B TTM
2.08
Market Cap
$119.47M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Alpha Cognition Inc. in?

Alpha Cognition Inc. (ACOG) operates in the Biological Products, (No Diagnostic Substances) industry.

What is ACOG's market cap?

Alpha Cognition Inc. (ACOG) has a market capitalization of $119.47M as of 2026-03-31.

What exchange does ACOG trade on?

Alpha Cognition Inc. (ACOG) trades on the Nasdaq.

Where is Alpha Cognition Inc. incorporated?

Alpha Cognition Inc. is incorporated in British Columbia, Canada.

Research Faster.
Invest Smarter.

Alpha Cognition Inc. (ACOG) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 90+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.